Drug discovery > Target Discovery Products & Reviews

An expanding portfolio of NGS panels for research into haematological and solid tumour cancers, as well as library preparation kits for the accurate detection of a wide range of genetic aberrations

The SureSeq™ Myeloid Plus NGS Complete Workflow combines the rapid Universal NGS Workflow hybridisation-based target enrichment method together with OGT’s expert bait design to detect 49 key genes implicated in myeloid disorders.

The SureSeq™ CLL + CNV Panel has been designed in collaboration with recognised cancer experts to detect 13 key genes and 5 chromosomal regions implicated in CLL progression (Table 1). The SureSeq CLL + CNV Panel alleviates the burden of running multiple assays and streamlines your CLL research to deliver a comprehensive genomic profile for each CLL sample using a single workflow

Myeloproliferative neoplasms (MPNs) are a heterogeneous group of diseases characterised by the overproduction of one or more types of blood cells. The SureSeq™ Core MPN Panel has been designed in collaboration with recognised cancer experts to detect somatic variants in 3 clinically relevant MPN associated genes; JAK2, MPL and CALR.  

The complete library preparation solution for unparalleled next generation sequencing (NGS) results. Based on scientists’ feedback, we have redesigned our workflow to ensure scientists achieve the most optimal NGS libraries, with one library preparation workflow across both our SureSeq™ and CytoSure® Constitutional NGS products.

High quality, reliable and easy-to-use DNA probes for fluorescence in situ hybridisation (FISH)

High quality, reliable and easy-to-use DNA probes for fluorescence in situ hybridisation (FISH)

CytoCell myProbes® is a custom design and manufacture service that provides unique fluorescence in situ hybridisation (FISH) probes using the BAC-2-FISH™ process.

IVDR certified probes now available!

Interpret is OGT’s powerful and easy-to-use next-generation sequencing analysis solution.